Helen Chen

L.E.K. Consulting is a global strategy consulting firm that specializes in corporate strategy, transaction services, and performance improvement. Founded in 1983, we now have more than 1,500 professionals located across major economies worldwide. Clients include Fortune 500, FTSE 100, Eurotop 300, and many of the largest firms in Asia-Pacific.

 

With a reputation for solving the most complex issues, L.E.K. collaborates closely with business leaders and their teams to accelerate the pace and precision of strategic decision-making. L.E.K. works across numerous industry sectors including a strong focus on the healthcare sector.

 

As a leading strategic advisor to the life sciences industry, L.E.K.’s clients include the largest and most advanced pharmaceutical, biotech, medical devices, tools and diagnostics companies. L.E.K.’s global team of life sciences professionals has expertise across all major industry segments and therapeutic areas, and we provide support at each stage of the product life cycle, from drug discovery to commercial optimisation.

 

L.E.K. hosts the Asia Pacific Life Sciences Centre of Excellence in partnership with the Singapore Economic Development Board (“EDB”). This Centre of Excellence (“CoE”) drives thought leadership and innovation to elevate the life sciences ecosystem both in Singapore and across the region.

Website:
www.lek.com
Helen Chen
L.E.K. Consulting
LinkedIn logo Greater China Managing Partner 

Guofeng Cheng China

Biotech
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
AusperBio
CEO 

Mr. Xinwei Cheng United States

Drug delivery antibody gene
Website:
www.luye.com
Company Size (Fulltime employees)
Year of foundation
2012
Partnering Objectives
Please specify your partnering goal
Looking for science and service
Headquartner in China
Luye Boston
Senior Scientists 
Functionality

Mr. Cliff Cheng China

A pharmaceutical company
Website:
www.buchang.com
Company Size (Fulltime employees)
Please specify your partnering goal
licensing-in and partnership
Headquartner in China
Buchang Pharma Group
CSO 

Wei Cheng

Public trade pharmaceutical company
Website:
Www.Fibrogen.com
Partnering Objectives
Headquartner in China
Fibrogen
Executive director 

Changfu Cheng United States

Dear Prospect Customer:

I would like to introduce my company (TDM Pharmaceutical Research, Inc) to you. TDM Pharmaceutical Research, INC, is a highly productive, intensely focused, quality-oriented CRO; we are experienced, well established, and driven by scientific merit. As a full-service GLP and GCP compliant laboratory, TDM offers a variety of discovery, research, development, bioanalytical, and consulting services to support discovery and development of pharmaceutical and chemical products. We pride ourselves on prompt data turnaround and addressing our clients’ needs with the accuracy and quality that are critical to their businesses.

TDM is uniquely different from other CROs: our over 90 years of combined industry experience allows us to resolve complex issues by providing comprehensive solutions in pharmacokinetics, toxicokinetics, pharmacokinetic/pharmacodynamic correlations, and more.

We are experienced in both the sponsor and the CRO position, so we anticipate and address the needs of our clients. Resourceful, committed personnel provide proactive support throughout each project, and respond to potential issues immediately.

Our myriad clients include both companies and individuals in the pharmaceutical and related industries. By selecting TDM as the partner for your next project, you will find we take each job and its needs personally; our focus is always on the client!

If you have any question, please feel free to contact me at: changfu.cheng@tdmrxresearch.com, or phone at 1-774-258-2425.

Thanks!

 

Changfu Cheng, PhD

President

TDM Pharmaceutical Research, Inc

https://tdmpharmalab.com

Company Size (Fulltime employees)
Year of foundation
1996
Please specify your partnering goal
IND of our drug candidates
Headquartner in China
Biotech/Pharma Category
Assets Information 1
FLUORINE- AND/OR DEUTERIUM-CONTAINING COMPOUNDS FOR TREATING NON-SMALL CELL LUNG CANCER AND RELATED DISEASES, US patent 10,633,367
Assets Information 2
DEUTERATED COMPOUNDS FOR TREATING FABRY, GAUCHER, PARKINSON’S AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF. US patent 10,519,157
Biotech/Pharma Asset Stage
Slides Deck
(pdf, 802.42KB)
TMD Pharmaceutical Research
President 
Functionality

Haipeng Cheng China

Sangel Capital provides venture capital and business finance to support high-tech enterprises in China and US. The firm seeks to invest in innovative startups in sectors including biopharma, diagnostics, medical devices, and biotech.
Sangel Capital was founded in 2010 and is based in Shenzhen, Beijing with additional offices in Suzhou and Chicago.
Sangel Capital

Mr. Eugene Chiu United States

Strategic investor
Website:
www.iqt.org
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
investments
Headquartner in China
IQT
Senior Partner 
Functionality

Mr. Chris Chow China

Hong Kong Biotechnology Organization is an independent nonprofit organization with the goal to promote best practice, raise awareness across the biotechnology industry while providing added value benefits to its members, whether they are students, researchers, entrepreneurs, industry bodies, public or private sector representatives.

Founded by pioneering scientists with extensive life science backgrounds and multi-cultural experience in research and development, engineering and business. Hong Kong Biotechnology Organization aims to establish and facilitate a worldwide platform for the Hong Kong biotech industry, promote awareness, encouraging and enabling international collaboration. We also provide informed opinion and technical advice to government bodies, healthcare institutions and the general public.
Company Size (Fulltime employees)
Year of foundation
2010
Partnering Objectives
Please specify your partnering goal
International Convention in Hong Kong
Headquartner in China
Your Research Tool and Service name
BIOHK2021
Service Description
Hong Kong Biotechnology Organization is going to hold an International Biotechnology Convention in Hong Kong in 2021. BIOHK2021 guarantees the perfect opportunity to best tap into this vast market, completing our biotech ecosystem as Asia emerges as the world’s next biotech powerhouse. BIOHK2021 is fully supported by HKSAR Government, where the Innovation and Technology Commission and Commerce has provided funding for our conference and the Commerce and Economic Development Bureau has made BIOHK2021 a key project in Hong Kong’s “relaunch program”. Furthermore, the event is also supported by the Torch Project from The Ministry of Science and Technology PRC. (Quoted: President Xi Jinping said ‘the Central Government will promote collaboration between Hong Kong and the Mainland on the technology front and support Hong Kong to become an international innovation and technology hub.’). These commitments to BIOHK2021 prove how essential and important the convention will be.
Target client type
All biotech stakeholders
Hong Kong Biotechnology Organization
Sales Manager 
Functionality

Mr. Edward Clark United Kingdom

PHASTAR is a specialist biometrics CRO offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships.

Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal quality, inspired by 3,700 years accumulated technical experience across the company.

PHASTAR is headquartered in London (UK) and North Carolina (US) and has 12 offices across five continents. PHASTAR is also currently in the process of setting up an office in Shangai, China. 

Company Size (Fulltime employees)
Year of foundation
2207
Partnering Objectives
Please specify your partnering goal
Share the organsiations biometrics capabilities
Headquartner in China
Your Research Tool and Service name
Biometrics
Phastar
Director